
==== Front
Cureus
Cureus
2168-8184
Cureus
2168-8184
Cureus Palo Alto (CA)

10.7759/cureus.67204
Genetics
Ophthalmology
Ocular Albinism, Telecanthus, and Skin Depigmentation: A Phenotypic Conundrum
Muacevic Alexander
Adler John R
López-Fontanet José J 1
Ramos-Sánchez Raúl Y 2
Izquierdo Natalio 3
1 Department of Ophthalmology, University of Puerto Rico, Medical Sciences Campus, San Juan, PRI
2 Department of Otolaryngology-Head and Neck Surgery, University of Puerto Rico, Medical Sciences Campus, San Juan, PRI
3 Department of Surgery, University of Puerto Rico, Medical Sciences Campus, San Juan, PRI
José J. López-Fontanet jose.lopez86@upr.edu
19 8 2024
8 2024
16 8 e6720419 8 2024
Copyright © 2024, López-Fontanet et al.
2024
López-Fontanet et al.
https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This article is available from https://www.cureus.com/articles/281142-ocular-albinism-telecanthus-and-skin-depigmentation-a-phenotypic-conundrum
This case report details the clinical manifestations observed in a 22-year-old male diagnosed with ocular albinism (OA). The patient underwent a comprehensive eye examination by one of the authors, revealing clinical features such as skin depigmentation, telecanthus, iris transillumination, nystagmus, and foveal hypoplasia. This report underscores the importance of a thorough clinical examination and genetic testing for accurate diagnosis, effective management, and appropriate counseling of patients with OA.

iris transillumination
nystagmus
skin depigmentation
telecanthus
ocular albinism
==== Body
pmcIntroduction

Ocular albinism (OA) is a hereditary eye disease characterized by a lack of pigment in the eyes, leading to various visual abnormalities [1]. Common ocular manifestations include nystagmus, photophobia, low visual acuity, iris transillumination (91% of the patients), and foveal hypoplasia [2-4]. Systemic manifestations may include hypopigmentation of the skin and hair.

The incidence of OA varies among different populations, but it is a rare condition affecting approximately 1 in 60,000 individuals [1]. OA is typically inherited as an X-linked recessive trait, with the most common mutation being in the GPR143 gene [1,5]. Mutations in the GPR143 gene lead to the development of oversized melanosomes with decreased motility and reduced quantity within melanocytes and retinal pigment epithelial cells [6,7]. Diagnosis is primarily based on clinical features. However, genetic testing confirms the clinical diagnosis and identifies a specific mutation leading to OA. We report on a patient with OA, wide intercanthal distance, foveal hypoplasia, and areas of skin hypopigmented macules.

Case presentation

A 22-year-old male patient with a history of low visual acuity and nystagmus since childhood underwent a comprehensive ophthalmic evaluation by one of the authors (N.I.E.). The patient reported no medical history; his family history, including his maternal uncles and grandparents, revealed no abnormalities or pertinent ocular or dermatologic conditions.

The best corrected visual acuity was 0.7 and 0.6 in the right (oculus dextrus, OD) and left eye (oculus sinister, OS), respectively (logarithm of the minimum angle of resolution). Refraction was -1.75 + 3.50 × 90° and -3.00 + 2.50 × 90° for the OD and OS, respectively. As shown in Figure 1, the intercanthal distance measured 40 mm, the interpupillary distance was 66 mm, and the outer canthal distance was 90 mm, with a W index of 2.14, confirming telecanthus.

Figure 1 A frontal view of the patient's face, illustrating the measurements of the intercanthal distance, interpupillary distance, and outer canthal distance. To respect the patient's privacy, the interpupillary distance is marked with the patient's eyes closed, indicating the location of the pupils

Upon slit lamp examination, as depicted in Figure 2, the patient had peripheral iris transillumination. Fundus examination revealed normal optic nerves and vessels. Additionally, there was a lack of foveal and macular pigmentation, with the presence of albinotic mid-peripheries. The patient's macular optical coherence tomography (Carl Zeiss Meditec, Inc., Dublin, CA) shows foveal hypoplasia, classified as grade 3 based on morphologic features, with a 207-micron OD and 236-micron OS thickness. The total macular volume measured 5.67 mm³ OD and 6.26 mm³ OS, as depicted in Figure 3.

Figure 2 Peripheral iris transillumination. The black arrow demarcates the intraocular lens, while the white arrow demarcates the peripheral transillumination

Figure 3 Optical coherence tomography examination of the macula. The macula of the (A) right and (B) left eyes shows loss of the foveal pit with grade 3 foveal hypoplasia

Upon visual field evaluation using the 30-2 protocol by Humphrey Field Analyzer 3 (Carl Zeiss Meditec, Inc.), the patient had a statistically significant mean deviation of -9.26 dB (p < 0.5%) OD and -3.89 dB (p < 1%) OS, along with a pattern standard deviation of +6.61 dB (p < 0.5%) OD and +4.30 dB (p < 0.5%) OS.

Upon systemic physical examination, the patient had skin patchy depigmentation in the posterior aspect of both elbows and the medial area of the right thigh, as shown in Figures 4, 5. The patient was referred to a dermatologist for a differential diagnosis of hypopigmented skin lesions, including Waardenburg syndrome, vitiligo, and piebaldism. Vitiligo was ruled out with histopathologic studies.

Figure 4 (A,B) A visual depiction of the skin patchy depigmentation observed in the posterior aspect of both elbows of the patient

Figure 5 A visual depiction of the skin patchy depigmentation observed in the medial thigh of the patient

Audiologic testing showed bilateral normal hearing. Impedance audiometry results indicated normal middle ear function in both ears, confirmed by consistent otoacoustic emissions.

Next-generation gene sequencing and deletion/duplication analysis were performed using the Invitae Corporation (San Francisco, CA) gene panel for dermatologic diseases. The results showed a hemizygous missense mutation in gene GPR143 c.905A>G (p.Gln302Arg), reported as a variant of uncertain significance.

Discussion

OA is a hereditary disease primarily affecting the eyes, with common manifestations such as nystagmus, iris transillumination, and foveal hypoplasia. It is typically inherited in an X-linked recessive manner, with the GPR143 gene being the most frequently implicated gene. Our patient had poor vision, nystagmus, iris transillumination, and foveal hypoplasia. This was confirmed with optical coherence tomography that showed loss of the foveal pit and reduced foveal thickness, as depicted in Figure 3. These findings correlate with the literature on OA.

Previous studies have reported on patients with Waardenburg syndrome as having hypopigmented macules and telecanthus, hearing loss, and changes in hair, skin, and pigmentary iris changes [8], which can sometimes present with symptoms overlapping with OA. Our patient did not have audiology problems but had an increased intercanthal distance, measuring 40 mm. This feature is not a primary characteristic of OA. To our knowledge, this is the first report of telecanthus in a patient with OA.

Vitiligo is an autoimmune disease that leads to skin depigmentation [9]. Our patient presented with hypopigmented macules on both elbows and the right thigh, which raised the suspicion of vitiligo as part of the differential diagnosis. However, after further evaluation by a dermatologist, vitiligo was excluded in this patient.

Previous studies have reported on the ocular findings of patients with OA due to the X-linked GPR143 gene mutations [1]. Our patient’s findings are compatible with the literature. However, genetic testing proved pivotal in reaching this patient's diagnosis. To our knowledge, this is the first report of this gene variant (c.905A>G (p.Gln302Arg)) leading to OA.

Conclusions

Patients with OA require a comprehensive ophthalmic and physical examination. In this case, the patient had phenotypic variations that can be associated with other diseases, highlighting the importance of a thorough clinical evaluation coupled with genetic testing, which accurately diagnoses and manages patients with OA.

While genetic testing has become an increasingly valuable tool for diagnosing and managing OA patients, it is essential to acknowledge its technological limitations. Challenges such as variants of unknown significance, incomplete testing, and unidentified related genes should be considered when interpreting genetic findings.

Disclosures

Author Contributions

Human subjects: Consent was obtained or waived by all participants in this study.

Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following:

Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work.

Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work.

Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Concept and design:  José J. López-Fontanet, Raúl Y. Ramos-Sánchez, Natalio Izquierdo

Acquisition, analysis, or interpretation of data:  José J. López-Fontanet, Raúl Y. Ramos-Sánchez, Natalio Izquierdo

Drafting of the manuscript:  José J. López-Fontanet, Raúl Y. Ramos-Sánchez, Natalio Izquierdo

Critical review of the manuscript for important intellectual content:  José J. López-Fontanet, Raúl Y. Ramos-Sánchez, Natalio Izquierdo

Supervision:  Natalio Izquierdo
==== Refs
References

1 X-linked ocular albinism Adv Exp Med Biol Tsang SH Sharma T 49 52 1085 2018 30578484
2 The phenotypic spectrum of albinism Ophthalmology Kruijt CC de Wit GC Bergen AA Florijn RJ Schalij-Delfos NE van Genderen MM 1953 1960 125 2018 30098354
3 Clinical and oculomotor characteristics of albinism compared to FRMD7 associated infantile nystagmus Invest Ophthalmol Vis Sci Kumar A Gottlob I McLean RJ Thomas S Thomas MG Proudlock FA 2306 2313 52 2011 21220551
4 Oculocutaneous albinism and ocular albinism overview GeneReviews Thomas MG Zippin J Brooks BP Seattle, WA University of Washington 2023 https://www.ncbi.nlm.nih.gov/books/NBK590568/
5 GPR143 genotypic and ocular phenotypic characterisation in a Chinese cohort with ocular albinism Ophthalmic Genet Zhong J You B Xu K Zhang X Xie Y Li Y 717 724 42 2021 34346269
6 Macromelanosomes in X-linked ocular albinism Histopathology Garner A Jay BS 243 254 4 1980 7390409
7 The ocular albinism type 1 protein, an intracellular G protein-coupled receptor, regulates melanosome transport in pigment cells Hum Mol Genet Palmisano I Bagnato P Palmigiano A 3487 3501 17 2008 18697795
8 Waardenburg syndrome type 1 Indian J Ophthalmol Agrawal R Walia S 2679 2681 70 2022 35791202
9 Vitiligo: a review Dermatology Bergqvist C Ezzedine K 571 592 236 2020 32155629
